Document:

Exhibit
10.17

 

Consultancy
Agreement

 

This Consultancy Agreement (the “Agreement”)
is made By and Between:

 

P.V. Nano Cell Ltd., Israeli
company number 514287093, of HaMasger Street 8, Migdal Haemek, POB 236, 23100, Israel (the “Company”); and

 

Mr. Meni Biran, Israeli ID No.
055997910, of 6 Lakov St., Hertzliya, Israel (the “Consultant”); and

 

	Whereas	the Company wishes to retain the Consultant as an independent contractor, to serve as the Company's VP Sales and Marketing and
to provide the Company with certain Services, as further detailed in Schedule A and as provided in this Agreement
(the “Services”), and the Consultant agrees to provide such Services.

 

Now, Therefore, the parties
have agreed as follows:

 

		1.	Consultancy Agreement

 

		1.1	The preamble hereto and the appendices attached hereto form integral and binding parts of this Agreement.

 

		1.2	The Company hereby retains the Consultant, and the Consultant agrees to act as the Company's VP Sales and Marketing and to provide the Company with the Services, effective as June 18th 2015 (the "Effective Date"). The scope of the Services will be as set forth in Schedule A. 

 

Following termination of
this Agreement, on September 1, 2015, the Parties will evaluate and review the possibility of hiring the Consultant as a full time
employee of the Company. If the parties will agree on that date to continue their engagement in the framework of employment relationship,
the Consultant's terms of employment for a full time position shall substantially include the following: (1) Gross monthly salary
in the amount of NIS 22,400; (2) payment for overtime hours in the amount of NIS 5,600 per month; (3) study fund (7.5%- Company
and 2.5%- employee) on the Gross monthly salary and overtime hours; (4) Benevolent Fund-Bituach Menahalim: the company will pay
a minimum of 13.33% and up to a maximum of 15.83% (as of the employees polisot) on the Gross monthly salary and overtime hours
(5) car allowance in the amount of NIS 5,000 not including fuel and route 6 expenses which will be paid by the company; (6) 17
annual vacation days per year following one year of employment; (7) two weeks prior notice if termination is provided at will during
the first year of employment, and after June 18th 2016 one month prior notice if termination is provided; (8) reimbursement
for expenses (including mobile phone expenses fuel and route 6 expenses).

 

		1.3	The Consultant will provide the Services personally, and may not assign or sub-contract the performance of the Services to any third party, without the prior written consent of the Company.

 

		1.4	The Consultant agrees to dedicate his best experience, talent, expertise and knowledge for the provision of the Services, and to perform the Services in a loyal and dedicated manner, and in accordance with the reasonable policy and instructions of the Company's CEO, VP Operations or any other person appointed by the Company.

 

		1.5	During the term of this Agreement, the Consultant shall not engage in any activity, commercial or otherwise, if such activity can reasonably be expected to create or assist a conflict of interests or competition with the Company.

 

    	 

    	 	 	 

    

 

		1.6	The Company may approve a change in the position, reporting structure, title, responsibilities and authority of the Consultant; and such change shall not be considered a breach of this Agreement provided, however, that Consultant's remuneration shall not be derogated from.

 

		1.7	The Consultant confirms that he does not bring and was not required to bring to the Company any proprietary materials of third parties, and that the Consultant is under no restrictions regarding the rendering of the Services to the Company and the execution of this Agreement.

 

		1.8	The Consultant is an independent contractor. The parties do not intend, and this Agreement and the performance of the Services hereunder shall not be construed to give effect to employment, partnership, joint venture or agency relations between the parties and the Consultant undertakes not to present any claims against the Company in that regard.

 

		1.9	should the Consultant or any other party on its behalf present any other claim against the Company, whether based upon allegation of employee-employer relations or otherwise, the Consultant will indemnify and hold the Company harmless for and against such claims, and the Company may offset any consideration it may owe to the Consultant against such claims.

 

		1.10	The Consultant is not allowed to obligate and/or bind the Company in any way and/or create any commitments on the Company's behalf, except as required for the performance of the Services and as authorized by the Company.

 

		1.11	The Consultant shall perform the Services according to all laws, rules and regulations applicable to the Consultant. Without derogating from the above said, the Consultant specifically warrants that he shall comply with all applicable rules and regulations concerning the prevention of corruption, money laundering and terrorism, and in accordance thereto.
	 	 	 
		1.12
	The consultant will need to come to PVN premises not more than three days a week, average, which will be coordinated with the VP
Operations or CEO. Regardless the consultant will perform all his agreed duties.

 

		2.	Remuneration

 

		2.1	Options: subject to the approval of the Board of Directors of the Company, the Company will issue to the Consultant options to purchase ordinary shares of the Company par value NIS 0.01 each, in the amount, on such vesting schedule and at an exercise price to be determined by the Board of Directors of the Company, and pursuant to the provisions of the Company’s 2010 Option Plan and an Option Award Agreement to be signed by and between the Company and the Consultant.

 

		2.2	Leased Car: The Company will provide the Consultant with a leased car and will pay for the fuel expenses by cash upon fuel gas station invoices in accordance with the Company’s procedures related to the use of Company's leased cars.

 

		2.3	The parties confirm that the remuneration described in this Chapter 2 is the full and exclusive remuneration due to the Consultant for the Services hereunder.

 

    	2

    	 	 	 

    

 

		3.	Secrecy and other Intellectual Property Issues

 

		3.1	The Consultant undertakes to execute, perform and abide by the Secrecy and Intellectual Property Undertaking as attached hereto as Schedule B.

 

		4.	Period of the Agreement

 

		4.1	This Agreement is made for a period commencing on the Effective Date and ending on September 1, 2015, subject to the right of each party to terminate it earlier upon a 14 days prior written notice to the other party.

 

		4.2	In addition, the Company shall have a right to terminate this Agreement immediately – if termination is made for Cause. The term “Cause” in this Agreement shall be defined as any of the following events or acts of the Consultant: (i) dishonesty, willful disobedience of any lawful order or instruction given by the Company through its managers; (ii) conviction for any criminal offence; or (iii) material breach of this Agreement which has not been rectified within 7 days of prior notice, breach of confidence or loyalty by the Consultant. 

 

		4.3	Except as provided by law, termination of this Agreement is without liability of the Company for any claims or payments beyond those earned or accrued in the course of the Services hereunder; and the Consultant hereby waives any and all such claims towards the Company, its affiliates and any other third party. Without derogating from the generality of the aforementioned, termination of this Agreement will not entitle either party to any compensation.

 

		5.	General Provisions

 

		5.1	This Agreement forms the complete and exclusive agreement between the parties as to its subject matter; and it cancels any prior verbal or written agreement related thereto. Any change to this Agreement requires a duly signed document.

 

		5.2	Any notice sent by one party to the other by registered mail will be deemed to have been received on the third business day after the day of mailing. Fax and electronic messages will be deemed to have been received on the business day following the day of transmission.

 

		5.3	The failure or delay of either party to require the performance of any term under this Agreement, or the waiver by either party of any breach under this Agreement, shall not prevent subsequent enforcement of such terms, nor be deemed a waiver of any subsequent or prolonged breach.

 

		5.4	This Agreement shall be governed by and construed in accordance with the laws of the State of Israel, without giving effect to the rules respecting conflict of law. The parties hereby irrevocably submit to the jurisdiction of the courts in the City of Haifa in respect of any dispute or matter arising out of or connected with this Agreement.

 

And
in Witness hereof the parties sign and execute this Agreement on June 17, 2015

 

 

	
        The Company

         

        
	 	
        The Consultant

         

         

        

	P.V. NANO CELL LTD.	 	Mr. Meni Biran

 

    	3

    	 	 	 

    

 

SCHEDULE A

 

Services and Scope:

 

		1.	The Consultant's Services shall include: 

 

	 	·	_______________________________________________________.

 

	 	·	_______________________________________________________.

 

	 	·	_______________________________________________________.

 

	 	·	_______________________________________________________.

 

    	4

    	 	 	 

    

 

SCHEDULE
B

 

SECRECY
AND INTELLECTUAL PROPERTY UNDERTAKING

 

In consideration of the disclosure by
the Company to the Consultant of information relating to the Services and the remuneration as set out in Section 2 of the Agreement,
the Consultant agrees as follows:

 

		1.	The term “Proprietary Information” means any and all confidential and/or proprietary knowledge, data or information of the Company or of any third party which is disclosed to Consultant or which he otherwise obtains or generates as a result of the Services (including the implications, results and applications of the Services and any knowhow, intellectual property and other rights relating to the results of the Services), including without limitation technical, business, marketing, financial, administrative, management and commercial information related to the Company, its products, current or prospective, knowhow, technology, trade secrets, software, copyright, process, commercial relations, actual and potential clients and suppliers, business or other plans, and any other information of a proprietary or confidential nature. Without derogating from the generality of the above said, information which by nature is deemed to be proprietary and non-public information and any information discussed and presented at any meeting of the Company in which the Consultant attended shall also be recognized as Proprietary Information.

 

		2.	The term “Proprietary Information” does not include information (i) which is, at the date of signature hereof or thereafter, enters the public domain, through no act or omission by the Consultant, (ii) information which was known to Consultant prior to its disclosure (in the case of information disclosed by Company) or prior to its generation (in the case of Proprietary Information generated by Consultant), as evidenced by his written records at the time of disclosure or generation (as applicable), (iii) information developed independently by Consultant without use of or reference to the Proprietary Information, as demonstrated by documentary evidence, (iv) information received by Consultant at any time from other sources that were legally entitled to receive and transfer such information without any obligation of confidentiality to Company.

 

		3.	Proprietary Information is recognized by Consultant as being confidential and the exclusive and sole property of the Company. 

 

		4.	The Consultant undertakes to maintain the confidentiality of the Proprietary Information, not to disclose or make available to any third party any of the Proprietary Information nor to make any use or enable others to make any use thereof other than for purposes of the Services, without the express prior written approval of the Company. 

 

		 	If required by law, Consultant may disclose Proprietary Information to a governmental authority or by order of a court of competent jurisdiction, provided that (a) unless restricted by such authority, Consultant shall immediately notify Company and take reasonable steps to assist Company in contesting such request, requirement or order or otherwise protecting Company’s rights and (b) Consultant shall limit the scope of such disclosure only to such portion of the Proprietary Information that it is legally required to disclose.

 

    	5

    	 	 	 

    

 

		 	The confidentiality and non-use obligations contained herein will remain valid and binding regardless of the termination of the Agreement and shall survive for a period of seven (7) years from the date of termination of this Agreement, and with respect to technological and technical information of the Company including trade secrets, the post termination period of compliance shall remain until said information comes into the public domain through no fault of the Consultant.

 

		5.	The term “Proprietary Rights” shall mean all inventions, discoveries, ideas, know-how, works of authorship and confidential information, including copyrights, patents and patent applications, trade secrets, trademarks, service marks, design marks, any registrations or applications relating to any of the foregoing. 

 

Inventions, if any, patented
or unpatented, made by Consultant prior to the date of this Agreement are excluded from the scope of this Agreement.

 

Consultant hereby assigns
and agrees to assign in the future (when any such inventions or Proprietary Rights are first reduced to practice or first fixed
in a tangible medium, as applicable) to the Company all his right, title and interest in and to any and all Proprietary Rights
whether or not patentable or registrable under copyright or similar statutes, made or conceived or reduced to practice or generated
by Consultant, either alone or jointly with others, in the performance of Services for the Company. Inventions assigned to the
Company, or to a third party as directed by the Company pursuant to this Section 5, are hereinafter referred to as “Company
Inventions.”

 

The Consultant acknowledges
that all original works of authorship which are made by Consultant (solely or jointly with others) in the performance of the Services
for the Company and which are protectable by copyright are “works made for hire” and are the property of the Company
pursuant to applicable copyright law. Any assignment of copyright hereunder (and any ownership of a copyright as a work made for
hire) includes all rights of paternity, integrity, disclosure and withdrawal and any other rights that may be known as or referred
to as “moral rights” (collectively “Moral Rights”). To the extent such Moral Rights cannot be assigned
under applicable law and to the extent the following is allowed by the laws in the various countries where Moral Rights exist,
Consultant hereby waives such Moral Rights and consents to any action of the Company that would violate such Moral Rights in the
absence of such consent including the right to prevent changes in such works and/or to be named in his name.

 

    	6

    	 	 	 

    

 

Consultant will assist the
Company in every proper way to obtain, and from time to time enforce, any patent rights relating to Company Inventions in any and
all countries, at Company’s expense. To that end Consultant will execute, verify and deliver such documents and perform such
other acts (including appearances as a witness) as the Company may reasonably request for use in applying for, obtaining, perfecting,
evidencing, sustaining and enforcing such patent rights and the assignment thereof. In addition, Consultant will execute, verify
and deliver such assignments of such patent rights to the Company or its designee as the Company may reasonably request. The Company
shall compensate Consultant at a reasonable rate for the time actually spent by Consultant at the Company’s request on such
assistance. Consultant's obligation to assist the Company with respect to patent rights relating to such Company Inventions in
any and all countries shall continue beyond the termination of this Agreement.

 

Consultant hereby agrees
that he shall not be entitled to any additional compensation for the assignments described in this Section 5 above and beyond the
consideration set forth in the Agreement. The Consultant acknowledges and agrees that he will not be entitled to additional royalties,
consideration or other payments with regard to any of the Proprietary Rights assigned to Company as set forth above, and does hereby
explicitly, irrevocably and unconditionally waive the right to receive any such additional royalties, consideration or other payments.

 

		6.	The Consultant shall not use any third party's intellectual property, materials, documents, other resources or confidential information in the performance of the Services. 

 

		7.	The Consultant shall report to the Company’s CEO during the period of the Agreement of his intention to provide services which creates conflict of interest between his other business interests and her position as a consultant to the Company. Within ten (10) business days from such notification, the Company shall inform the Consultant whether it wishes to continue with the terms of the Agreement or, at its sole discretion, terminate it with immediate effect.

 

		8.	Upon termination of the Agreement, the Consultant shall immediately return to the Company or delete from his network all materials of any kind (whether in written or electronic form, computer files or otherwise) concerning the Proprietary Information, including all copies thereof, and he shall not retain any copies of such materials and shall erase such from all of his files and records in any format.

 

And in Witness hereof the parties
sign and execute this Schedule B on June 17, 2015

 

 

	P.V. NANO CELL LTD.	 	Mr. Meni Biran

 

 

7Exhibit 10.18

  

P.V. NANO CELL LTD.

 

2010
OPTION PLAN

 

	1.	NAME

 

This plan, as amended
from time to time, shall be known as the P.V. Nano Cell Ltd. 2010 Option Plan (the "Plan").

 

	2.	PURPOSE OF THE PLAN AND SCOPE

 

	 	The purpose and intent of the Plan is to serve as an incentive to attract new employees, directors, consultants and service providers, and to retain in the employment of P.V. Nano Cell Ltd. (the “Company”) persons of training, experience and ability by providing them with opportunities to purchase securities, including shares of the Company, pursuant to the Plan, as approved by the board of directors of the Company (the "Board").

 

This Plan shall serve as
an “Umbrella Plan” for the Company worldwide, and therefore, as required, additional annexes may be attached to the
Plan as to comply with any local law applicable in any other country, all subject to Board’s sole discretion.

 

Securities (options and
shares) granted under this Plan shall be issued as to adhere to all applicable laws, including but not limited to the Israeli Income
Tax Ordinance (New Version), 1961 and any regulations, rules, orders or procedures promulgated thereunder, as may be amended from
time to time (all jointly referred to as the “Ordinance”).

 

Accordingly, the securities,
including shares of the Company and options to purchase shares of the Company, granted under the Plan may be subject to such terms
and conditions, which shall deem such issued securities to securities issued under a Trustee Scheme Plan or any other scheme, allowable
and compliant with the law. All of the abovementioned securities shall be referred to as the “Securities”, in
addition, all of the securities which are options shall be referred to as the “Options”.

 

At any time, the Board may
resolve to translate this Plan into English and to approve the English version and determine that it shall prevail. The translation
of this Plan will be conducted in such a manner as to preserve the essence/meaning and content of the Hebrew version even if the
translation is not an exact verbal translation of the original.

 

	3.	ADMINISTRATION

 

	3.1	The Board or a committee appointed by the Board for such purpose (the "Committee") shall have the power to administer the Plan. The Board shall appoint the members of the Committee, and may from time to time add members to or replace member of the Committee. Notwithstanding the above, the Board shall automatically have a residual authority if no Committee shall be constituted or if such Committee shall cease to operate for any reason. In this Plan any reference to the term “Committee” shall also mean the Board, if at that time no Committee is operating in the Company.

 

    	- 1 -

    	 

    

 

Non Binding Translation

 

	3.2	The Committee shall select one of its members as its chairman and shall hold its meetings at such times and places, as the chairman shall determine. Actions at a meeting of the Committee at which a majority of its members is present or acts approved in writing by all of the members of the Committee, shall be the valid acts of the Committee. The Committee shall make such rules and regulations for the conduct of its business and shall appoint a secretary, who shall keep records of its meetings.

 

	3.3	The Committee shall fulfill the following tasks: (i) designate grantees entitled to receive Securities (each referred to in this Plan as the “Grantee” or the “Participant”) and (ii) recommend to the Board to grant Securities to the Grantees. Without derogating from the foregoing, the Board shall be authorized to issue the underlying shares on behalf of the Company with respect to Options, which have been granted and duly exercised (the “Underlying Shares”). If permitted under the Articles of Association of the Company (the “Articles”) and with the Board’s consent, the Committee may be authorized to grant Securities and issue the Underlying Shares on behalf of the Company, provided such grant and issuance are within the frame of the reserved pool under the Plan and subject to the Board’s guidelines.

 

	3.4	Subject to the provisions of this Plan, the Committee shall have full authority and discretion to determine, from time to time and at any time, the terms and conditions of respective Securities grant agreements to be signed between the Company and each Grantee individually (“Grant Agreement”) including, but not limited to: (i) the type of Securities, including the type of Options, granted; (ii) the time or times and the conditions (including without limitation the accomplishment of various milestones by the Grantee) upon which the Securities may be exercised (vested); (iii) the nature and duration of restrictions regarding the transferability of Securities and Underlying Shares; (iv) additional special terms and conditions exclusive to a certain Grantee.

 

The Committee shall be authorized
to: (i) interpret the provisions, manage and supervise the administration of the Plan; (ii) amend, modify and replace terms and
conditions of a specific Grant Agreement or a number of Grant Agreements, (provided however, that such act in one case or for one
or several Grantee/s, will not automatically entitle any other Grantee to the same treatment, and provided that a material adverse
change in any executed Grant Agreement requires the consent of the affected Grantee); (iii) convert un-vested Options granted under
this Plan and/or convert the Securities with a re-purchase option, allowing the Company to re-purchase such Securities, granted
under this Plan during the re-purchase into Options and/or Securities under any future Plan adopted by the Company – subject
to applicable laws; and (vi) any other matter which is necessary or desirable for, or incidental to, the administration of the
Plan.

 

    	- 2 -

    	 

    

 

Non Binding Translation

 

	3.5	The Committee may from time to time adopt such rules and regulations for carrying out the Plan as it may deem best. No member of the Board or of the Committee shall be liable for any act or determination made in good faith with respect to the Plan or any Security granted thereunder.

 

	3.6	A member of the Board or the Committee shall be eligible to receive Securities under the Plan while serving on the Board or the Committee, subject to the provisions of the Israeli Companies Law 1999 (the “Companies Law” or the “Law”).

 

	3.7	The interpretation and construction by the Committee of any provision of the Plan or with respect to any Security awarded thereunder shall be final and conclusive unless otherwise determined by the Board.

 

	3.8	To the fullest extent permitted by applicable laws, each member of the Board or the Committee shall be indemnified and held harmless by the Company against any cost or expense (including counsel fees) reasonably incurred by him or her, or any liability (including any sum paid in settlement of a claim with the approval of the Company) arising out of any act or omission to act in connection with the Plan, unless arising out of such member's own fraud or bad faith or constitute the breach of the duty of loyalty. Such indemnification shall be in addition to any rights of indemnification the member of the Board or of a Committee may have as a director or an office-holder under the Company's Articles, any agreement, any vote of shareholders or disinterested directors, insurance policy or otherwise.

 

	4.	ELIGIBLE GRANTEES

 

	4.1	Subject to limitation and restriction imposed by applicable law, Securities may be granted to any Office Holder ("Nose Misra" as such term is defined in the Companies Law), key employee, other employee of the Company, consultant or service provider of the Company provided, however, that: (1) employees taxed under the laws of the State of Israel shall be granted Securities only according to Section 102 of the Ordinance; (2) holders of controlling interest (as such term is defined in the Ordinance), consultants and service providers taxed under the laws of the State of Israel shall be granted with Securities only according to Section 3(i) of the Ordinance. 

 

	4.2	The grant of a Security to a Grantee, shall neither entitle such Grantee to participate, nor disqualify him/her from participating, in any other grant of Securities pursuant to this Plan or any other share incentive or share option plan of the Company or any of its affiliated companies.

 

	4.3	Notwithstanding anything in this Plan to the contrary, the grant of Securities to the Office Holders shall be approved in accordance with the procedure set forth in the Companies Law.

 

	4.4	The Company has initially elected the Capital Gains Trustee scheme to apply to this Plan regarding all Grantees who are taxed under Israeli laws and are eligible to be included in such a scheme as provided by the Ordinance.

 

The Board may resolve, from
time to time, to change the above tax scheme to Ordinary Income scheme as provided for in accordance with the provisions terms
of the Ordinance, although such resolution shall not apply to the grants of Securities effective before the date of such resolution.

 

    	- 3 -

    	 

    

 

Non Binding Translation

 

	5.	TRUSTEE & CERTAIN PROVISIONS UNDER SECTION 102 TO THE ORDINANCE

 

	5.1	Any Security granted under the trustee scheme and all the Underlying Shares of the Company to be issue upon the exercise of Option granted under the trustee scheme, shall be held by a trustee designated by the Board (the "Trustee") according to the terms of the Ordinance and pursuant to a trust agreement approved by the Board, a copy of which is attached hereto and forms an integral part of the Plan (the “Trust Agreement”), and in accordance with the Company's instructions, as provided for from time to time. Each Grantee awarded with Securities under Capital Gain Trustee Scheme, hereby consents to the terms of the Trust Agreement, which includes provisions regarding indemnification and waiver by the Grantee.

 

	5.2	The Grantee’s signature on the Grant Agreement constitutes the Grantee’s consent to release the Trustee from any liability in respect of any act or decision taken and executed by the Trustee in good faith regarding the Plan or any Security granted to the Grantee. It is clarified that the Trustee shall serve as a trustee for the purpose of tax payments and the fulfillment of the relevant sections of the Ordinance, and shall not serve as a trustee of a Participant or the Company, except as provided in the Trust Agreement. 

 

	5.3	The Trustee may resign and the Company may terminate the appointment of the Trustee at any time, subject to prior notice as required by the Trust Agreement. The Company may, at its sole discretion, determine the identity of the new Trustee.

 

	5.4	Without derogating from any of the provisions set forth in the Ordinance the following restrictions shall apply:

 

	 	5.4.1	According to the provisions of Section 102 to the Ordinance, the Securities granted under the trustee scheme shall be issued in the name of the Trustee and shall be held by him in trust in favor of each Grantee for the period commencing as of the day the Securities were deposited in to his trust, and ending not earlier than the end of the Restricted Period as defined in Section 102 of the Ordinance (the “Restricted Period”). During the Restricted Period, the Securities may not be exercised, sold, transferred or be subject of an attachment or security interest, unless permitted and to the extent permitted under the Ordinance.

 

    	- 4 -

    	 

    

 

Non Binding Translation

 

	 	5.4.2	At the end of the Restricted Period, the Trustee shall release the Securities and/or the Underlying Shares to the Grantee upon such Grantee’s request, only after the Trustee has been satisfied that all the requirements of the Tax Authorities according to the Ordinance have been met (including payment of the applicable tax due). 

 

	 	5.4.3	All rights received on the Securities during the Restricted Period, including among others share dividends (bonus shares), shall be deposited with the Trustee as well for the duration of the Restricted Period, and the provisions of the Capital Gains Scheme along with the provisions of Section 102 of the Ordinance shall apply to the above rights.

 

	 	5.4.4	If the Grantee ceases to work for the Company prior to his exercise of all the Options granted to him and before such Grantee has sold all of the Securities granted to him, including the Underlying Shares, the Grantee shall provide the Company with a security or guarantee, satisfactory to the Company, to ensure the timely payment of the taxes as due.

 

	6.	RESERVED SHARES 

 

Initially, the Company has,
out of its registered an un-issued share capital, reserved up to 63,150 Ordinary shares, nominal value NIS 0.01 per
share (the “Shares” or the “Ordinary Shares”) for the Plan, subject to adjustment, if any,
as provided for in Section 11 below. The Board may increase such number of reserved Shares from time to time.

 

For as long as the Plan
shall be in effect, each of the above reserved Share in respect of which the Option for which it was reserved has expired for any
reason or has terminated without being exercised, shall again be available for grant under the Plan.

 

	7.	AWARD OF SECURITIES

 

	7.1	The Committee in its discretion may award Securities, including Options to purchase Shares in the Company, all pursuant to the Plan. Securities may be granted under the Plan during the term of the Plan as provided in Section 13 below. The date of grant of each Security shall be the date specified by the Committee at the time such grant is made.

 

	7.2	Securities granted pursuant to the Plan shall be evidenced by a written Grant Agreement. The Grant Agreement shall state, inter alia, the number of Securities granted, the dates when such Securities become vested or on the contrary, the date until which the Company may repurchase such Securities from the Grantee, the exercise price, scheme under which Securities are granted, terms and condition of exercise and such other terms and conditions as the Committee in its discretion may determine.

 

    	- 5 -

    	 

    

 

Non Binding Translation

 

	7.3	In case the Securities are granted under the trustee scheme, they may be exercised during the period as set forth in section 9.1 below.

 

	8.	SECURITY PRICE/OPTION EXERCISE PRICE

 

The price per each Security
or the exercise price per each Option into Share, shall be determined by the Committee, subject to the general guidelines provided
by the Board from time to time, and provided that the price/exercise price shall not lower than the nominal value of the Shares.
Each vested Option shall entitle the Grantee to purchase one Share against payment of the exercise price and subject to the provisions
of the Plan, the Grant Agreement, the Trust Agreement (if relevant) and the applicable rules, including Tax Rules.

 

	9.	TERM AND EXERCISE OF SECURITIES AND OPTIONS

 

	9.1	Vested Securities may be exercised at any time during the Exercised Period, provided that the Exercised Period shall in no event exceed the period of seven (7) years from the date such Security has been granted, although a longer or shorter period may be explicitly determined as to a certain Grant Agreement. Such Exercise Period shall be subject to earlier termination, as provided for in sections 10 and 11 below (the “Exercise Period ”).

 

	 	The Vesting Schedule according to which each Security shall become vested, as set forth in the Notice of Grant, shall be extended in the event of an unpaid leave of absence by the period equal to the period of such leave.

 

	9.2	Vested Option shall be deemed exercised Option, when the Company (and the Trustee, if applicable) has received at its principal office an Exercise Notice signed by the Grantee. The Exercise Notice shall be in such form and substance as provided by the Committee from time to time. The Exercise Notice shall be valid only if it is accompanied by due payment of the exercise price, all according to the Ordinance.

 

	9.3	Notwithstanding all the above, any Option that has not been exercised within the Exercise Period, including non-payment of the exercise price for the Underlying Shares, such Option shall expire, and the Participant shall have no right with respect to such Option. If a trust with respect to such Options has been created, this trust shall expire and the reserved Shares shall be held by the trustee under un-allocated until the Company notifies the Trustee of a new grant underlying such Shares. In respect of Securities, other then Options, if the price for such Securities is not paid during the required period, such Securities shall expire and the Participant shall have no right with respect to such Securities.

 

	9.4	Payment of the exercise price, shall be made for a whole number of Shares without the right to acquire fractional Shares, and shall be made by cash or certified banker’s check payable to the order of the Company or by any other means acceptable by the Company. Such payment shall be accompanied by an Exercise Notice.

 

    	- 6 -

    	 

    

 

Non Binding Translation

  

	9.5	For as long as the Options have not been exercised into Shares pursuant to the terms set forth in this Plan, Option holders shall not be deemed to be a separate class of shareholders or creditors of the Company for purpose of the operation of the Companies Law, including among others with respect to Sections 341, 350 and 351 to the Companies Law and they shall not be subject to the provisions of Sections 148 and 185 to the Companies Law.

 

If the Securities granted
were Shares, they shall not grant the Participant with any rights as of a shareholder in the Company for as long as the full price,
as determined, is paid.

 

	10.	TERMINATION OF ENGAGEMENT

 

	10.1	In the event of termination of Grantee's employment with the Company, or in the event of termination of consulting or provider’ services provided by a Grantee, that is a consultant or service provider of the Company (together: “Engagement Termination”), all Options granted to such Grantee, which have become vested prior to the date of the Termination of Engagement, may be exercised within six (6) months after the date of such termination (or such other period as may be determined by the Committee) (the “Grace Period”), provided that such date is no later than the Exercise Period date as provided for in the Plan or in the Grant Agreement (if a different Exercise Periods had been determined). All Options of such Grantee that have not vested prior to the Engagement Termination date and all vested Options that have not been exercised within the exercise period, shall expire, and the Grantee shall have no further rights with respect thereto. The Shares covered by such Options shall revert to the Plan for future grants.

 

In case of Securities granted
with a repurchase option to the Company, the Company may exercise its repurchase option within six (6) months after the date of
the Engagement Termination, regarding such Securities which repurchase option has not yet expired

 

	10.2	Termination
    for Cause. Notwithstanding the above, in the event of termination of the Grantee’s engagement in the Company for “Cause”
    as hereinafter defined, all unexercised Securities of such Grantee (whether vested or not) shall immediately expire, unless
    determined otherwise by the Committee and the Grantee shall have no further rights with respect thereto.

 

In this Plan the term “Cause”
shall mean (i) conviction of any felony involving dishonor/moral turpitude or having an adverse effect on the Company; (ii) any
breach of a material provision in the employment agreement and/or in this agreement which has not been amended within 15 days of
written notice; (iii) embezzlement of funds or assets of the Company; (iv) a breach of Grantee's fiduciary duties or duties of
care to the Company; including without limitation disclosure of confidential information of the Company or breach of non-competition
or non-use obligations.

 

    	- 7 -

    	 

    

 

Non Binding Translation

 

	10.3	Retirement. Without derogating from the aforementioned in Section 10.2 above, in the event of a Grantee’s retirement, the Committee may, at its sole discretion, determine as to an extended Exercise Period for such Grantee, pursuant to such terms and conditions as the Committee in its sole discretion may determine. At the end of such extended Exercise Period all Options shall expire, and the Grantee shall have no further rights with respect thereto. The abovementioned shall not be relevant to the Grantee who is a corporate entity (not a natural person).

 

	10.4	Termination of engagement as a result of Death or Disability of the Grantee. In the event of termination of Grantee's engagement with the Company by reason of death or Disability (as hereinafter defined), those Securities of the Grantee that are then vested may be exercised by the Grantee, the Grantee's legal guardian, the Grantee’s estate or a person who acquires the right to exercise the Securities by bequest or inheritance, as the case may be, within twelve (12) months after such termination (or such different period as may be determined by the Committee), but in no event later than the Exercise Period as set forth in the Grant Agreement. All the Shares covered by the Securities that have not become vested as of the Engagement Termination date shall revert to the Plan. 

 

In
case of Shares with a repurchase option, the Company may exercise its repurchase option.

 

If
vested Securities are not so exercised within the time specified herein, such Securities shall expire, the Shares covered thereby
shall revert to the Plan and the Grantee and anyone on his behalf or in his stead shall have no further rights with respect thereto.

 

For
purposes hereof, "Disability" shall mean complete and permanent inability, due to illness or injury, that prevents or
is likely to prevent from the Participant to perform duties associated with the position in which he/she was engaged prior to appearance
of such disability, as shall be determined by the Committee based on medical evidence acceptable to it. Section 10.4 herein shall
not apply regarding Grantees which are non-natural persons.

 

	10.5	Post Termination forfeiture. Notwithstanding the reason of the Engagement Termination, if during the period after the Engagement Termination and prior to the exercise of vested Securities, the Grantee breaches any of the foregoing undertakings, the Company shall have the right to effect a forfeiture of all Securities held by such Grantee, and such Grantee shall have no further rights with respect thereto, and the Underlying Shares shall revert to the Plan. Such undertakings include: the non-disclosure, non-competition, non-solicitation, non-use or assignment of intellectual property undertakings binding upon him/her, the non-signature of information transfer forms in favor of the Company.

 

    	- 8 -

    	 

    

 

Non Binding Translation

 

	10.6	Continuity of rights. For the purpose of this Section 10, a Grantee’s relocation from the employment with the Company to that of a subsidiary of the Company (and vice versa) and a change in the status of a consultant or a service providers to an employee of the Company (and vice versa), shall not be deemed an Engagement Termination to the extent permitted by law.

 

	11.	ADJUSTMENTS AND SUBSTITUTION 

 

Upon the occurrence of any
of the following events, a Grantee's rights under the Plan shall be adjusted or substituted as hereinafter provided:

 

	11.1	In the event that the Ordinary Shares of the Company are subdivided or combined into a greater or smaller number of shares, as the case may be, or if the Ordinary Shares of the Company are exchanged for other securities of the Company, then each Grantee granted with Securities shall be entitled to receive such number shares or other securities instead of such Securities as exchangeable for such number of Securities according to the modification of the share capital of the Company.

 

If the Grantee was granted
with Options, in the event as described above, such Grantee shall, upon exercise of the Options, be entitled to purchase such number
of Ordinary Shares or such other securities of the Company as were exchangeable for the number of Ordinary Shares of the Company
or number of other securities to which such Ordinary Shares have been exchanged, which such Grantee would have been entitled to
purchase had the Grantee exercised the Options immediately prior to such an event, and appropriate adjustments shall be made in
the exercise price per share to reflect such subdivision, combination, exchange or any other adjustment.

 

	11.2	In the event of a merger of the Company with or into another corporation whereby the Company is not the surviving entity, or the sale of all or substantially all of the assets or shares of the Company (the “Transaction”), while at such time the Grantee or Grantees remain holding outstanding Securities under the Plan, that have not previously been exercised, then the Company shall try to substitute the Securities with the corresponding and adjusted number of securities of the surviving entity. The number of new securities shall grant the Participant the right to purchase securities of the surviving entity of the same class and the same substitution rate as the shares received by the holders of Ordinary Shares of the Company in exchange for their Ordinary Shares. In the case of such substitution, appropriate adjustments shall be made in the quantity and exercise price to reflect such action.

 

In the event that the
surviving entity refuses to substitute the Securities as provided above, the Exercise Period shall be shortened to the determining
date (as determined by the Committee) prior to the Transaction completion. In the event that the Securities are not substituted
as provided above, there shall be a partial acceleration of the Vesting Period of un-vested Securities in the manner that the number
of vested Securities divided by the total number of the granted Securities multiplied by the number of un-vested Securities will
be accelerated and become granted Securities.

 

    	- 9 -

    	 

    

 

Non Binding Translation

 

Below are a few examples:

 

	 	Ex.	 	Number of 
Granted 
Securities	 	 	Number of 
Vested 
Securities	 	 	Number of 
Un-vested 
Securities	 	 	Calculation	 	 	Total Number 
Of Granted 
Securities	 
	 	1.	 	 	400	 	 	 	100	 	 	 	300	 	 	 	100 + (300 x 100/400)	 	 	 	175	 
	 	2.	 	 	400	 	 	 	200	 	 	 	200	 	 	 	200 + (200 x 200/400)	 	 	 	300	 
	 	3.	 	 	400	 	 	 	300	 	 	 	100	 	 	 	300 + (100 x 300/400)	 	 	 	375	 

 

The Securities that
become vested as a result of the above partial acceleration, shall be subject to the same terms and conditions as the Securities
that were already vested prior to the Transaction, including the provisions of section 11.2. Any Security that has not been exercised
within the shortened Exercise Period shall expire upon the expiration of such shortened period. Without derogating the foregoing,
the Committee may, at its sole discretion, conclude in various Grant Agreements additional rights with regard to acceleration of
vesting period of unvested Securities in the event of a Transaction as stated above or on other circumstances.

 

The provisions as stated
above shall be subject to and consummated simultaneously with the closing of a Transaction. In the even of no closing of the Transaction,
any action taken pursuant to this Sub-Section 11.2 shall be annulled and reverted back to as were previously in effect.

 

	11.3	In the event that the Company issues any of its Ordinary Shares or other securities as bonus shares (stock dividend) upon or with respect to all its Ordinary Shares, which are at the time subject to a right of purchase by a Grantee hereunder, each Grantee upon exercising a Security shall be entitled to receive, if he/she so elects, in addition to the Underlying Shares, the appropriate number of bonus shares, on the same terms and conditions as offered to the other ordinary shareholders, which he/she would have received had the exercise of the Securities taken place prior to such issuance.

 

	11.4	The Committee shall determine the specific adjustments to be made under this Section 11, and its determination shall be conclusive. The Committee’s determination may differ from one Grantee to another, except that determination of specific adjustment under Sections 11.1 and 11.3 shall be applied in the same manner to all applicable Grantees.

 

	12	ASSIGNABILITY
    AND SALE OF SHARES

 

	12.1	Shares exercised under this Plan, shall not be assignable or transferable except pursuant to applicable laws and according to the Articles of the Company.

 

    	- 10 -

    	 

    

 

Non Binding Translation

 

	12.2	Securities may not be sold, pledged, assigned, hypothecated, or transferred in any manner other than by will or if inherited by the laws of descent and may be exercised, during the lifetime of the Grantee, only by the Grantee. Such restrictions of transferability shall apply to any direct transfer of Securities or to any transfer that is a result of a change of control in the corporate entity, unless such transfer is approved by the Committee in writing, at its sole discretion. The terms of the Plan and the Grant Agreement shall be binding upon the executors, administrators, heirs, successors and assigns of the Grantee.

 

	13.	PERIOD AND AMENDMENT OF THE PLAN

 

	13.1	The Plan shall expire within 10 years following its approval by the Board.

 

	13.2	The Board may, at any time and from time to time, terminate or amend the Plan in any respect, provided, that the Company may not alter or impair the material rights of a Grantee, without his/her consent.

 

	14.	CONTINUANCE OF ENGAGEMENT

 

Neither the Plan nor
the Grant Agreement shall impose any obligation on the Company or any affiliated company thereof, to continue the employment of
any employee or to continue to receive services rendered by the Grantee, and nothing in the Plan or in the Grant Agreement or in
any Security granted pursuant thereto shall confer upon any Grantee any right to continue in the employ of or in rendering services
to the Company or restrict the right of the Company to terminate such employment or service provision at any time, with or without
Cause.

 

	15.	GOVERNING LAW

 

The Plan and all instruments
issued thereunder or in connection therewith, shall be governed by, and interpreted in accordance with, the laws of the State of
Israel.

 

	16.	TAX CONSEQUENCES

 

Any tax consequences
arising from the grant or exercise of any Security or from the payment for Shares or from sale or transfer of the Shares or from
any other event or act hereunder (whether of the Grantee or of the Company or the Trustee), shall be borne solely by the Grantee.
The Company and/or the Trustee shall withhold and/or deduct taxes according to all applicable laws, rules, and regulations, including
withholding taxes at source.

 

It is hereby clarified
that the grant of the Securities under the capital gain scheme does not guarantee the Grantee the reduced tax, arising from the
exercise of all or part of the granted Securities.

 

    	- 11 -

    	 

    

 

Non Binding Translation

 

Furthermore, each Grantee
agrees to compensate and to indemnify the Company and/or the Trustee and/or the Company’s shareholders and/or directors and/or
officers and hold them harmless against and from any and all liability for any such tax or interest or penalty thereon, including
without limitation, liabilities relating to the necessity to withhold, or to have withheld, any such tax from any payment made
to the Grantee. Except as otherwise required by law, the Company shall not be obligated to honor the exercise of any Security by
or on behalf of a Grantee until all tax consequences (if any) arising from the exercise of such Securities and/or sale of Underlying
Shares and/or any other action are resolved in a manner reasonably acceptable to the Company (and the Trustee – provided
that the Options/Shares are under a Trustee Scheme).

 

	17.	MULTIPLE AGREEMENTS

 

The terms of each Grant
Agreement may differ from other Grant Agreements signed at the same time, or at any other time. The Committee may grant a Participant
additional Securities to those previously granted to him, and it may include different terms in such grant. The grant of different
Securities may be evidenced by a single Notice of Grant or multiple Notices of Grant, as determined by the Committee.

 

	18.	NON-EXCLUSIVITY OF THE PLAN

 

The adoption of the Plan
by the Board shall not be construed as amending, modifying or rescinding any previously approved incentive arrangement or as creating
any limitations on the power of the Board to adopt such other incentive arrangements as it may deem desirable, including, without
limitation, the granting of Securities otherwise than under the Plan, and such arrangements may be either applicable generally
or only in specific cases.

  

 

**********************************

 

- 12 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00249-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00249-of-00352.parquet"}]]